Infectious Disease Diagnostics – News and Features

Company is building momentum in Personalized Healthcare with FDA approval of therascreen EGFR companion diagnostic and new pharma co-development projects.

Next generation smart phone technologies to be developed to enable doctors to test and track serious infectious diseases.

A new test for diagnosing TB in children detects roughly two-thirds of cases identified by the current culture test, but in a fraction of the time.

This innovative test that aids in identifying an important respiratory pathogen is a strong addition to the illumigene platform.

Researchers at Duke University will lead the initiative.

Achieves Q1 2013 targets: Net sales of $303.6 million grow 3% CER on expansion in all regions; adjusted diluted EPS at $0.23 per share; free cash flow of $30 million.

A*STAR and Veredus Laboratories announced the launch of VereTrop(TM) that can identify 13 different major tropical diseases from a single blood sample.

The new Mobidiag to offer integrated, high-multiplex diagnostic tests for infectious diseases.

The novel method points to new blood tests for conditions from Alzheimer’s to autoimmune diseases.

Company has received a £2.6m($4.3m) strategic translation award from the Wellcome Trust.